Logo image of ENVIP.OL

ENVIPCO HOLDING NV (ENVIP.OL) Stock Fundamental Analysis

Europe - OSL:ENVIP - NL0015000GX8 - Common Stock

62.8 NOK
-4.6 (-6.82%)
Last: 10/15/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ENVIP. ENVIP was compared to 103 industry peers in the Machinery industry. ENVIP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ENVIP has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ENVIP had negative earnings in the past year.
In the past year ENVIP has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: ENVIP reported negative net income in multiple years.
In multiple years ENVIP reported negative operating cash flow during the last 5 years.
ENVIP.OL Yearly Net Income VS EBIT VS OCF VS FCFENVIP.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.17%, ENVIP is doing worse than 79.61% of the companies in the same industry.
ENVIP's Return On Equity of -12.91% is on the low side compared to the rest of the industry. ENVIP is outperformed by 79.61% of its industry peers.
Industry RankSector Rank
ROA -6.17%
ROE -12.91%
ROIC N/A
ROA(3y)-2.29%
ROA(5y)-2.04%
ROE(3y)-6.03%
ROE(5y)-4.88%
ROIC(3y)N/A
ROIC(5y)N/A
ENVIP.OL Yearly ROA, ROE, ROICENVIP.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

Looking at the Gross Margin, with a value of 38.00%, ENVIP is in line with its industry, outperforming 46.60% of the companies in the same industry.
In the last couple of years the Gross Margin of ENVIP has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ENVIP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.12%
GM growth 5Y-0.13%
ENVIP.OL Yearly Profit, Operating, Gross MarginsENVIP.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

ENVIP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ENVIP has more shares outstanding
The number of shares outstanding for ENVIP has been increased compared to 5 years ago.
ENVIP has a worse debt/assets ratio than last year.
ENVIP.OL Yearly Shares OutstandingENVIP.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ENVIP.OL Yearly Total Debt VS Total AssetsENVIP.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 4.23 indicates that ENVIP is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.23, ENVIP belongs to the best of the industry, outperforming 84.47% of the companies in the same industry.
ENVIP has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.18, ENVIP is doing good in the industry, outperforming 68.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 4.23
ROIC/WACCN/A
WACC7.5%
ENVIP.OL Yearly LT Debt VS Equity VS FCFENVIP.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ENVIP has a Current Ratio of 1.74. This is a normal value and indicates that ENVIP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.74, ENVIP is in the better half of the industry, outperforming 61.16% of the companies in the same industry.
A Quick Ratio of 1.04 indicates that ENVIP should not have too much problems paying its short term obligations.
ENVIP has a Quick ratio (1.04) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.04
ENVIP.OL Yearly Current Assets VS Current LiabilitesENVIP.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

ENVIP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -180.00%.
The Revenue has decreased by -9.30% in the past year.
Measured over the past years, ENVIP shows a very strong growth in Revenue. The Revenue has been growing by 25.76% on average per year.
EPS 1Y (TTM)-180%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)-9.3%
Revenue growth 3Y43.67%
Revenue growth 5Y25.76%
Sales Q2Q%-13.22%

3.2 Future

Based on estimates for the next years, ENVIP will show a very strong growth in Earnings Per Share. The EPS will grow by 308.76% on average per year.
ENVIP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 42.56% yearly.
EPS Next Y202%
EPS Next 2Y584.69%
EPS Next 3Y308.77%
EPS Next 5YN/A
Revenue Next Year26.53%
Revenue Next 2Y49.61%
Revenue Next 3Y42.56%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ENVIP.OL Yearly Revenue VS EstimatesENVIP.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
ENVIP.OL Yearly EPS VS EstimatesENVIP.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6

4

4. Valuation

4.1 Price/Earnings Ratio

ENVIP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 11.89, which indicates a very decent valuation of ENVIP.
ENVIP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ENVIP is cheaper than 61.16% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.04. ENVIP is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 11.89
ENVIP.OL Price Earnings VS Forward Price EarningsENVIP.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

81.55% of the companies in the same industry are cheaper than ENVIP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 54.01
ENVIP.OL Per share dataENVIP.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

ENVIP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ENVIP's earnings are expected to grow with 308.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y584.69%
EPS Next 3Y308.77%

0

5. Dividend

5.1 Amount

No dividends for ENVIP!.
Industry RankSector Rank
Dividend Yield N/A

ENVIPCO HOLDING NV

OSL:ENVIP (10/15/2025, 7:00:00 PM)

62.8

-4.6 (-6.82%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-12 2025-11-12
Inst Owners33.34%
Inst Owner ChangeN/A
Ins Owners35.08%
Ins Owner ChangeN/A
Market Cap4.15B
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-261.44%
Min EPS beat(2)-492.16%
Max EPS beat(2)-30.72%
EPS beat(4)0
Avg EPS beat(4)-186.85%
Min EPS beat(4)-492.16%
Max EPS beat(4)-30.72%
EPS beat(8)2
Avg EPS beat(8)-111.56%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.8%
Min Revenue beat(2)-24.86%
Max Revenue beat(2)-12.73%
Revenue beat(4)1
Avg Revenue beat(4)-10.14%
Min Revenue beat(4)-24.86%
Max Revenue beat(4)7.48%
Revenue beat(8)2
Avg Revenue beat(8)-7.33%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-77.78%
EPS NY rev (1m)0%
EPS NY rev (3m)-92.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-29.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.89
P/S 3.39
P/FCF N/A
P/OCF N/A
P/B 6.09
P/tB 8.07
EV/EBITDA 54.01
EPS(TTM)-0.94
EYN/A
EPS(NY)5.28
Fwd EY8.41%
FCF(TTM)-1.78
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS18.54
BVpS10.31
TBVpS7.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.17%
ROE -12.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38%
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-2.04%
ROE(3y)-6.03%
ROE(5y)-4.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.12%
GM growth 5Y-0.13%
F-Score3
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 1.49
Cap/Depr 100.25%
Cap/Sales 8.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.74
Quick Ratio 1.04
Altman-Z 4.23
F-Score3
WACC7.5%
ROIC/WACCN/A
Cap/Depr(3y)135.02%
Cap/Depr(5y)123.96%
Cap/Sales(3y)10.49%
Cap/Sales(5y)11.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-180%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y202%
EPS Next 2Y584.69%
EPS Next 3Y308.77%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.3%
Revenue growth 3Y43.67%
Revenue growth 5Y25.76%
Sales Q2Q%-13.22%
Revenue Next Year26.53%
Revenue Next 2Y49.61%
Revenue Next 3Y42.56%
Revenue Next 5YN/A
EBIT growth 1Y-124.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year345.56%
EBIT Next 3Y142.35%
EBIT Next 5YN/A
FCF growth 1Y44.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y90.31%
OCF growth 3YN/A
OCF growth 5YN/A